Related Experiment Video
Updated: Apr 25, 2026
07:26
Formation of Ordered Biomolecular Structures by the Self-assembly of Short Peptides
Published on: November 21, 2013
12.4K
Drug conjugation to cyclic peptide-polymer self-assembling nanotubes
Bianca M Blunden1, Robert Chapman, Maarten Danial
1Centre for Advanced Macromolecular Design, School of Chemistry, University of New South Wales, Sydney, NSW 2052 (Australia); Cooperative Research Centre (CRC) for Polymers, 8 Redwood Drive, Notting Hill, Victoria 3618 (Australia).
Chemistry (Weinheim an Der Bergstrasse, Germany)
|August 23, 2014
Summary
Novel polymeric nanotubes, formed from self-assembled polymer and cyclic peptide conjugates, efficiently carry the anticancer drug RAPTA-C. These drug-loaded nanotubes demonstrate significant activity against cancer cells.
Area of Science:
- Materials Science
- Nanotechnology
- Drug Delivery
Background:
- Polymeric nanotubes (NTs) are emerging as promising nanocarriers.
- Efficient drug delivery systems are crucial for cancer therapy.
- Self-assembly of polymers and peptides offers versatile nanostructure fabrication.
Purpose of the Study:
- To develop and characterize novel polymeric nanotubes for drug delivery.
- To investigate the potential of these nanotubes as carriers for the anticancer drug RAPTA-C.
- To evaluate the efficacy of drug-loaded nanotubes against cancer cells.
Main Methods:
- Synthesis of a statistical co-polymer of poly(2-hydroxyethyl acrylate) (pHEA) and poly(2-chloroethyl methacrylate) (pCEMA).
- Conjugation of the ruthenium-based anticancer drug RAPTA-C to the polymer.
- Self-assembly of the polymer-drug conjugate into nanotubes (200-500 nm length).
- In vitro evaluation of nanotube activity against cancer cells.
Main Results:
- Successfully fabricated polymeric nanotubes using self-assembled polymer-drug conjugates.
- The nanotubes effectively encapsulated and delivered the RAPTA-C drug.
- The resulting drug-loaded nanotubes exhibited high anticancer activity.
Conclusions:
- Polymeric nanotubes based on self-assembled polymer-cyclic peptide conjugates represent an efficient drug delivery platform.
- This approach offers a novel strategy for cancer therapy using targeted drug delivery.
- The developed nanocarriers show significant potential for clinical translation in oncology.
